![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SAMARITAN PHARMACEUTICALS INC. PURCHASES BACK CANADIAN RIGHTS FOR HIV DRUG FROM QUEST PHARMATECH
SAMARITAN PHARMACEUTICALS INC. PURCHASES BACK CANADIAN RIGHTS FOR HIV DRUG FROM QUEST PHARMATECH
Samaritan Pharmaceuticals Inc., a developer of innovative drugs, is pleased to announce it has purchased back the Canadian licensing rights related to HIV drug Anticort from Quest PharmaTech, Inc. (previously known as Altachem Pharma, Inc. and Steroidogenesis Inhibitors Canada, Inc.). Prime Zone (http://www.primezone.com/newsroom/news.html?ref=rss&d=103455)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct